Return on investment in pay for performance: a diabetes case study

Summary

The research paper "Return on investment in pay for performance: a diabetes case study" by Curtin, Beckman, Pankow, and Milillo, published in 2006, investigates the financial returns of a pay-for-performance (P4P) program focused on diabetes care within an HMO setting. The study specifically evaluated a private sector P4P initiative sponsored by Excellus Health Plan and implemented by the Rochester Individual Practice Association (RIPA). This analysis utilized data from 2003 and 2004 to track the projected spending trends associated with diabetes management. The methodology involved calculating the return on investment by comparing program costs to the healthcare cost savings achieved through improved diabetes care. The authors accounted for new spending required to provide previously underused services for managing diabetic patients. Key findings revealed a positive ROI, which increased over time. For the year 2003, the ROI was calculated at 1.6:1, improving to 2.5:1 in 2004. The study identified an average net savings of $2.4 million per year, which was directly attributed to the more reliable diabetes care facilitated by the P4P program. These savings were primarily driven by a reduction in hospitalizations, followed by decreases in physician costs, pharmacy expenses, and outpatient spending. The paper suggested that this was among the first reports to demonstrate a positive ROI for an HMO-based P4P program, thereby building a business case for continued development of such incentive-based healthcare models. While the study provided compelling evidence for the financial benefits of P4P in diabetes care, it is noted that these findings have not been widely replicated in other settings, making the generalizability of these specific results unclear.